SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.430.0%Dec 3 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harold Engstrom who wrote (794)11/18/2000 8:56:27 PM
From: scaram(o)uche   of 1475
 
>> any idea why BTRN still has such a low market cap? <<

1. long-term issues with xeno.... impatience of investors, and technical hurdles that need to be addressed.

2. MEDI

3. MEDI

4. difficulty with the concept of controlled graft-versus-host disease to fight lymphoid malignancies, and conceptual grapling with making it a "product".

5. MEDI

6. lack of appreciation for IP of SCS.

The independent company, yet to be named, will be public and IMO, at a monstrous capitalization some day. It's the "some day" that is intolerable to some investors, and MEDI's insights and speed aren't taking up the slack.

Let that be a lesson for those who might consider a collaboration with MEDI. Don't.

There are three routes to huge success with BTRN, and a couple of lesser ones. There's only one thing, however, to hang your "tomorrow" hat on..... 507.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News